Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.

ABSTRACT: Effective doctor-patient communication is critical for disease management, especially when considering genetic information. We studied patient-provider communications after implementing a point-of-care pharmacogenomic results delivery system to understand whether pharmacogenomic results are discussed and whether medication recall is impacted. Outpatients undergoing preemptive pharmacogenomic testing (cases), non-genotyped controls, and study providers were surveyed from October 2012-May 2017. Patient responses were compared between visits where pharmacogenomic results guided prescribing versus visits where pharmacogenomics did not guide prescribing. Provider knowledge of pharmacogenomics, before and during study participation, was also analyzed. Both providers and case patients frequently

SUBMITTER: Borden BA 

PROVIDER: S-EPMC6980369 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature